111 related articles for article (PubMed ID: 24780409)
1. Urine 6-sulfatoxymelatonin levels are inversely associated with arterial stiffness in post-menopausal women.
Lee JY; Lee DC
Maturitas; 2014 Jun; 78(2):117-22. PubMed ID: 24780409
[TBL] [Abstract][Full Text] [Related]
2. Association between urinary 6-sulfatoxymelatonin excretion and arterial stiffness in the general elderly population: the HEIJO-KYO cohort.
Obayashi K; Saeki K; Kurumatani N
J Clin Endocrinol Metab; 2014 Sep; 99(9):3233-9. PubMed ID: 24878050
[TBL] [Abstract][Full Text] [Related]
3. Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women.
Lee JY; Kim JH; Lee DC
Menopause; 2014 Jan; 21(1):39-44. PubMed ID: 23760432
[TBL] [Abstract][Full Text] [Related]
4. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels.
Schernhammer ES; Kroenke CH; Dowsett M; Folkerd E; Hankinson SE
J Pineal Res; 2006 Mar; 40(2):116-24. PubMed ID: 16441548
[TBL] [Abstract][Full Text] [Related]
5. Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.
Pérez-Caraballo AM; Ma Y; Ockene JK; Reeves KW; Balasubramanian R; Stanczyk FZ; Allison MA; Chen C; Wang L; Manson JE; Sturgeon SR
Chronobiol Int; 2018 Aug; 35(8):1115-1121. PubMed ID: 29750588
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility over 5 years of measurements of 6-sulphatoxymelatonin in urine samples from postmenopausal women.
Travis RC; Allen NE; Peeters PH; van Noord PA; Key TJ
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):806-8. PubMed ID: 12917214
[TBL] [Abstract][Full Text] [Related]
7. Association of Urinary 6-Sulfatoxymelatonin (aMT6s) Levels and Objective and Subjective Sleep Measures in Older Men: The MrOS Sleep Study.
Saksvik-Lehouillier I; Harrison SL; Marshall LM; Tranah GJ; Ensrud K; Ancoli-Israel S; Clemons A; Redline S; Stone KL; Schernhammer ES;
J Gerontol A Biol Sci Med Sci; 2015 Dec; 70(12):1569-77. PubMed ID: 26265731
[TBL] [Abstract][Full Text] [Related]
8. Melatonin and breast cancer: a prospective study.
Travis RC; Allen DS; Fentiman IS; Key TJ
J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
[TBL] [Abstract][Full Text] [Related]
9. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743
[TBL] [Abstract][Full Text] [Related]
10. Urinary melatonin: a noninvasive method to follow human pineal function as studied in three experimental conditions.
Pääkkönen T; Mäkinen TM; Leppäluoto J; Vakkuri O; Rintamäki H; Palinkas LA; Hassi J
J Pineal Res; 2006 Mar; 40(2):110-5. PubMed ID: 16441547
[TBL] [Abstract][Full Text] [Related]
11. Urinary melatonin and risk of ovarian cancer.
Poole EM; Schernhammer E; Mills L; Hankinson SE; Tworoger SS
Cancer Causes Control; 2015 Oct; 26(10):1501-6. PubMed ID: 26223889
[TBL] [Abstract][Full Text] [Related]
12. Normative data on the daily profile of urinary 6-sulfatoxymelatonin in healthy subjects between the ages of 20 and 84.
Mahlberg R; Tilmann A; Salewski L; Kunz D
Psychoneuroendocrinology; 2006 Jun; 31(5):634-41. PubMed ID: 16584848
[TBL] [Abstract][Full Text] [Related]
13. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.
Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES
Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174
[TBL] [Abstract][Full Text] [Related]
14. Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.
Rosen R; Hu DN; Perez V; Tai K; Yu GP; Chen M; Tone P; McCormick SA; Walsh J
Mol Vis; 2009 Aug; 15():1673-9. PubMed ID: 19710945
[TBL] [Abstract][Full Text] [Related]
15. Long-term alteration of daily melatonin, 6-sulfatoxymelatonin, cortisol, and temperature profiles in burn patients: a preliminary report.
Pina G; Brun J; Tissot S; Claustrat B
Chronobiol Int; 2010 Jan; 27(2):378-92. PubMed ID: 20370476
[TBL] [Abstract][Full Text] [Related]
16. Urinary melatonin levels and breast cancer risk.
Schernhammer ES; Hankinson SE
J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
[TBL] [Abstract][Full Text] [Related]
17. Urinary Melatonin in Relation to Breast Cancer Risk: Nested Case-Control Analysis in the DOM Study and Meta-analysis of Prospective Studies.
Wong ATY; Fensom GK; Key TJ; Onland-Moret NC; Tong TYN; Travis RC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):97-103. PubMed ID: 33144281
[TBL] [Abstract][Full Text] [Related]
18. Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.
Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Yu MC
Int J Cancer; 2013 Feb; 132(4):891-6. PubMed ID: 22644618
[TBL] [Abstract][Full Text] [Related]
19. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort.
Schernhammer ES; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):74-9. PubMed ID: 19124483
[TBL] [Abstract][Full Text] [Related]
20. The association of body size in early to mid-life with adult urinary 6-sulfatoxymelatonin levels among night shift health care workers.
Ramin CA; Massa J; Wegrzyn LR; Brown SB; Pierre-Paul J; Devore EE; Hankinson SE; Schernhammer ES
BMC Public Health; 2015 May; 15():467. PubMed ID: 25943349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
